Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme

被引:46
|
作者
Ohashi, Riuko [1 ,2 ,3 ,4 ]
Martignoni, Guido [5 ,6 ]
Hartmann, Arndt [7 ]
Calio, Anna [5 ]
Segala, Diego [6 ]
Stoehr, Christine [7 ]
Wach, Sven [8 ]
Erlmeier, Franziska [7 ,9 ]
Weichert, Wilko [9 ]
Autenrieth, Michael [10 ]
Schraml, Peter [2 ,3 ]
Rupp, Niels J. [2 ,3 ]
Ohe, Chisato [11 ]
Otsuki, Yoshiro [12 ]
Kawasaki, Takashi [13 ]
Kobayashi, Hiroshi [14 ]
Kobayashi, Kazuhiro [15 ]
Miyazaki, Tatsuhiko [15 ]
Shibuya, Hiroyuki [16 ]
Usuda, Hiroyuki [17 ]
Umezu, Hajime [18 ]
Fujishima, Fumiyoshi [19 ]
Furusato, Bungo [20 ,21 ]
Osakabe, Mitsumasa [22 ]
Sugai, Tamotsu [22 ]
Kuroda, Naoto [23 ]
Tsuzuki, Toyonori [24 ]
Nagashima, Yoji [25 ]
Ajioka, Yoichi [1 ,4 ]
Moch, Holger [2 ,3 ]
机构
[1] Niigata Univ, Histopathol Core Facil, Fac Med, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan
[2] Univ Zurich, Dept Pathol & Mol Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland
[3] Univ Hosp Zurich, Schmelzbergstr 12, CH-8091 Zurich, Switzerland
[4] Niigata Univ, Div Mol & Diagnost Pathol, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan
[5] Univ Verona, Dept Diagnost & Publ Hlth, Piazzale Ludovico Antonio Scuro 10, I-37134 Verona, Italy
[6] Pederzoli Hosp, Dept Pathol, Via Monte Baldo 24, I-37019 Peschiera Del Garda, Italy
[7] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany
[8] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Urol & Pediat Urol, Krankenhausstr 12, D-91054 Erlangen, Germany
[9] Tech Univ Munich, Inst Pathol, Trogerstr 18, D-81675 Munich, Germany
[10] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[11] Kansai Med Univ, Dept Pathol & Lab Med, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan
[12] Seirei Hamamatsu Gen Hosp, Dept Pathol, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan
[13] Niigata Canc Ctr Hosp, Dept Pathol, Chuo Ku, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[14] Tachikawa Gen Hosp, Dept Pathol, 1-24 Asahioka, Nagaoka, Niigata 9408621, Japan
[15] Gifu Univ Hosp, Dept Pathol, 1-1 Yanagido, Gifu 5011194, Japan
[16] Niigata City Gen Hosp, Dept Pathol, Chuo Ku, 463-7 Shumoku, Niigata 9501197, Japan
[17] Nagaoka Red Cross Hosp, Dept Diagnost Pathol, 2-297-1 Sensyu, Nagaoka, Niigata 9402085, Japan
[18] Niigata Univ Med & Dent Hosp, Div Pathol, Chuo Ku, 1-754 Asahimachi Dori, Niigata 9518520, Japan
[19] Tohoku Univ, Dept Anat Pathol, Grad Sch Med, Aoba Ku, 2-1 Seityo Machi, Sendai, Miyagi 9808575, Japan
[20] Nagasaki Univ Hosp, Clin Genom Ctr, Canc Genom Unit, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[21] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[22] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, 2-1-1 Idai Dori, Yahaba, Iwate 0283695, Japan
[23] Kochi Red Cross Hosp, Dept Diagnost Pathol, 1-4-63-11 Hadaminamimachi, Kochi, Kochi 7808562, Japan
[24] Aichi Med Univ Hosp, Dept Surg Pathol, 1-1 Yamkokarimata, Nagakute, Aichi 4801195, Japan
[25] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
基金
瑞士国家科学基金会;
关键词
Chromophobe renal cell carcinoma; Kidney; Mitosis; Necrosis; Prognosis; Sarcomatoid differentiation; The Cancer Genome Atlas (TCGA); Tumor grade; NEUROENDOCRINE; VALIDATION; PARAMETERS; FEATURES; OUTCOMES; SOCIETY; UTILITY; IMPACT; TUMOR;
D O I
10.1007/s00428-019-02710-w
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A histological grading system of chromophobe renal cell carcinoma (chRCC) is highly desirable to identify approximately 5-10% of tumors at risk for progression. Validation studies failed to demonstrate a correlation between the four-tiered WHO/ISUP grade and outcome. Previous proposals with three-tiered chromophobe grading systems could not be validated. In this study, the presence of sarcomatoid differentiation, necrosis, and mitosis was analyzed in a Swiss cohort (n = 42), an Italian cohort (n = 103), a German cohort (n = 54), a Japanese cohort (n = 119), and The Cancer Genome Atlas cohort (n = 64). All 3 histological parameters were significantly associated with shorter time to tumor progression and overall survival in univariate analysis. Interobserver variability for identification of these parameters was measured by Krippendorff's alpha coefficient and showed high concordance for the identification of sarcomatoid differentiation and tumor necrosis, but only low to medium concordance for the identification of mitosis. Therefore, we tested a two-tiered tumor grading system (low versus high grade) based only on the presence of sarcomatoid differentiation and/or necrosis finding in the combined cohorts (n = 382). pT stage, patient's age (> 65 vs <= 65), lymph node and/or distant metastasis, and the two-tiered grading system (low versus high grade) were significantly associated with overall survival and were independent prognostic parameters in multivariate analysis (Cox proportional hazard). This multi-institutional evaluation of prognostic parameters suggests tumor necrosis and sarcomatoid differentiation as reproducible components of a two-tiered chromophobe tumor grading system.
引用
收藏
页码:409 / 418
页数:10
相关论文
共 50 条
  • [21] International, Multi-Institutional Study of 1330 Patients Evaluating the Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Renal Cell Carcinoma
    Nabavizadeh, Reza
    Patil, Dattatraya H.
    Medline, Alexandra
    Fukuda, Shohei
    Yasuda, Yosuke
    Ogan, Kenneth
    Master, Viraj
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S338 - S339
  • [22] PROPOSAL FOR RECLASSIFICATION OF T1 AND T2A RENAL CELL CARCINOMA: RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS
    Meagher, Margaret
    Saidian, Ava
    Autorino, Riccardo
    Lane, Brian
    Fujii, Yasuhisa
    Marchioni, Michele
    Tanaka, Hajime
    Patil, Dattatraya
    Porpiglia, Francesco
    Noyes, Sabrina
    Nasseri, Ryan
    Sundaram, Chandru
    Porter, James
    Minervini, Andrea
    Capitanio, Umberto
    Montorsi, Francesco
    Master, Viraj
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2022, 207 (05): : E343 - E343
  • [23] Carcinoma of the fallopian tube: Results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors
    Alvarado-Cabrero, Isabel
    Stolnicu, Simona
    Kiyokawa, Takako
    Yamada, Kyosuke
    Nikaido, Takashi
    Santiago-Payan, Hector
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (02) : 159 - 164
  • [24] ABCC2 as a Prognostic Biomarker in Papillary Renal Cell Carcinoma: A Large, Multi-institutional Study of 254 Cases
    Masoomian, Mehdi
    Castillo, Vincent Francis
    Trpkov, Kiril
    Downes, Michelle
    Brimo, Fadi
    Van der Kwast, Theodorus
    Zakhary, Abraam
    Rotondo, Fabio
    Kidanewold, Wondwossen
    Saad, Gina
    Nguyen, Vy-nhan
    Streutker, Catherine
    Rowsell, Corwyn
    Saleeb, Rola
    LABORATORY INVESTIGATION, 2023, 103 (03) : S764 - S765
  • [25] Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
    Kim, Jung Kwon
    Kim, Sung Han
    Song, Mi Kyung
    Joo, Jungnam
    Seo, Seong Il
    Kwak, Cheol
    Jeong, Chang Wook
    Song, Cheryn
    Hwang, Eu Chang
    Seo, Ill Young
    Lee, Hakmin
    Hong, Sung-Hoo
    Park, Jae Young
    Chung, Jinsoo
    CANCER MEDICINE, 2019, 8 (07): : 3401 - 3410
  • [26] PREDICTING FACTORS FOR LATE RECURRENCE IN PATIENTS WITH T1 CLEAR-CELL RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL STUDY
    Ha, Yun Sok
    Kim, Jeong Hyun
    Park, Yong Hyun
    Kang, Seok Ho
    Hong, Sung Hoo
    Byun, Seok Soo
    Kim, Won Tae
    Yun, Seok Joong
    Kim, Yong June
    Kim, Isaac Yi
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A116 - A116
  • [27] Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: Multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes
    Abe, T.
    Shinohara, N.
    Muranaka, M.
    Sazawa, A.
    Maruyama, S.
    Osawa, T.
    Harabayashi, T.
    Kubota, K.
    Matsuno, Y.
    Shibata, T.
    Toyada, Y.
    Shinno, Y.
    Minami, K.
    Sakashita, S.
    Kumagai, A.
    Takada, N.
    Togashi, M.
    Sano, H.
    Mori, T.
    Nonomura, K.
    EJSO, 2010, 36 (11): : 1085 - 1091
  • [28] Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31 Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
    Ohashi, Riuko
    Hartmann, Arndt
    Martignoni, Guido
    Moch, Holger
    EUROPEAN UROLOGY, 2021, 80 (01) : E17 - E18
  • [29] C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan
    Tsujino, Takuya
    Komura, Kazumasa
    Hashimoto, Takeshi
    Muraoka, Ryu
    Satake, Naoya
    Matsunaga, Tomohisa
    Tsutsumi, Takeshi
    Yoshikawa, Yuki
    Takai, Tomoaki
    Minami, Koichiro
    Uehara, Hirofumi
    Hirano, Hajime
    Nomi, Hayahito
    Ibuki, Naokazu
    Takahara, Kiyoshi
    Inamoto, Teruo
    Ohno, Yoshio
    Azuma, Haruhito
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 812.e1 - 812.e8
  • [30] Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
    Mao, Weipu
    Sun, Si
    He, Ting
    Jin, Xin
    Wu, Jianping
    Xu, Bin
    Zhang, Guangyuan
    Wang, Keyi
    Chen, Ming
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6437 - 6450